Structure

Physi-Chem Properties

Molecular Weight:  415.19
Volume:  431.17
LogP:  3.309
LogD:  2.929
LogS:  -5.383
# Rotatable Bonds:  3
TPSA:  69.72
# H-Bond Aceptor:  6
# H-Bond Donor:  1
# Rings:  5
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.761
Synthetic Accessibility Score:  3.965
Fsp3:  0.32
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.89
MDCK Permeability:  3.4211232559755445e-05
Pgp-inhibitor:  0.999
Pgp-substrate:  0.027
Human Intestinal Absorption (HIA):  0.032
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.451

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.164
Plasma Protein Binding (PPB):  90.1595458984375%
Volume Distribution (VD):  0.457
Pgp-substrate:  9.438897132873535%

ADMET: Metabolism

CYP1A2-inhibitor:  0.035
CYP1A2-substrate:  0.11
CYP2C19-inhibitor:  0.914
CYP2C19-substrate:  0.835
CYP2C9-inhibitor:  0.878
CYP2C9-substrate:  0.882
CYP2D6-inhibitor:  0.211
CYP2D6-substrate:  0.182
CYP3A4-inhibitor:  0.896
CYP3A4-substrate:  0.93

ADMET: Excretion

Clearance (CL):  2.029
Half-life (T1/2):  0.308

ADMET: Toxicity

hERG Blockers:  0.008
Human Hepatotoxicity (H-HT):  0.899
Drug-inuced Liver Injury (DILI):  0.98
AMES Toxicity:  0.019
Rat Oral Acute Toxicity:  0.313
Maximum Recommended Daily Dose:  0.095
Skin Sensitization:  0.799
Carcinogencity:  0.11
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.039

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC355

Natural Product ID:  NPC355
Common Name*:   Acyl Aszonalenin
IUPAC Name:   n.a.
Synonyms:   Acyl Aszonalenin
Standard InCHIKey:  TXNJQKDZOVFCAQ-GRYUFTJMSA-N
Standard InCHI:  InChI=1S/C25H25N3O3/c1-5-24(3,4)25-14-20-21(30)26-18-12-8-6-10-16(18)22(31)28(20)23(25)27(15(2)29)19-13-9-7-11-17(19)25/h5-13,20,23H,1,14H2,2-4H3,(H,26,30)/t20-,23-,25+/m0/s1
SMILES:  C=CC(C)(C)[C@]12C[C@H]3C(=Nc4ccccc4C(=O)N3[C@@H]2N(C(=O)C)c2ccccc12)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL480101
PubChem CID:   44575660
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0001733] Pyrroloindoles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18099 Aspergillus flavipes Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[22329646]
NPO18099 Aspergillus flavipes Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[31674782]
NPO18099 Aspergillus flavipes Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[32568536]
NPO18099 Aspergillus flavipes Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[7517439]
NPO18099 Aspergillus flavipes Species Aspergillaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT297 Individual Protein Neurokinin 1 receptor Homo sapiens Ki = 170000.0 nM PMID[525181]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC355 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8436 Intermediate Similarity NPC106118
0.8427 Intermediate Similarity NPC471199
0.8312 Intermediate Similarity NPC122553
0.8242 Intermediate Similarity NPC68650
0.8054 Intermediate Similarity NPC295548
0.8023 Intermediate Similarity NPC470548
0.7968 Intermediate Similarity NPC225400
0.7926 Intermediate Similarity NPC471155
0.7926 Intermediate Similarity NPC470786
0.7926 Intermediate Similarity NPC472538
0.7884 Intermediate Similarity NPC270241
0.7772 Intermediate Similarity NPC472539
0.7772 Intermediate Similarity NPC472540
0.7772 Intermediate Similarity NPC470787
0.7765 Intermediate Similarity NPC307396
0.773 Intermediate Similarity NPC472541
0.773 Intermediate Similarity NPC472542
0.765 Intermediate Similarity NPC276430
0.7614 Intermediate Similarity NPC248601
0.756 Intermediate Similarity NPC117032
0.7544 Intermediate Similarity NPC471122
0.75 Intermediate Similarity NPC472102
0.75 Intermediate Similarity NPC309531
0.7471 Intermediate Similarity NPC471130
0.7471 Intermediate Similarity NPC471124
0.7458 Intermediate Similarity NPC177261
0.7457 Intermediate Similarity NPC472120
0.7457 Intermediate Similarity NPC472117
0.7457 Intermediate Similarity NPC472101
0.7423 Intermediate Similarity NPC315051
0.7387 Intermediate Similarity NPC244425
0.7387 Intermediate Similarity NPC15384
0.7374 Intermediate Similarity NPC475607
0.7371 Intermediate Similarity NPC472106
0.7362 Intermediate Similarity NPC469560
0.736 Intermediate Similarity NPC285622
0.7356 Intermediate Similarity NPC88970
0.7346 Intermediate Similarity NPC471123
0.7345 Intermediate Similarity NPC472118
0.7333 Intermediate Similarity NPC285192
0.7333 Intermediate Similarity NPC474081
0.7318 Intermediate Similarity NPC475594
0.73 Intermediate Similarity NPC471197
0.7293 Intermediate Similarity NPC475761
0.7284 Intermediate Similarity NPC300299
0.7283 Intermediate Similarity NPC113946
0.7264 Intermediate Similarity NPC471198
0.7262 Intermediate Similarity NPC324445
0.7232 Intermediate Similarity NPC279527
0.7232 Intermediate Similarity NPC214960
0.7225 Intermediate Similarity NPC84317
0.7216 Intermediate Similarity NPC189116
0.7205 Intermediate Similarity NPC207428
0.7198 Intermediate Similarity NPC475094
0.7198 Intermediate Similarity NPC474041
0.7193 Intermediate Similarity NPC66936
0.7184 Intermediate Similarity NPC104345
0.7143 Intermediate Similarity NPC471191
0.7143 Intermediate Similarity NPC316746
0.7143 Intermediate Similarity NPC154478
0.7143 Intermediate Similarity NPC36495
0.7128 Intermediate Similarity NPC471196
0.7128 Intermediate Similarity NPC471195
0.7117 Intermediate Similarity NPC162417
0.7117 Intermediate Similarity NPC316104
0.7112 Intermediate Similarity NPC473815
0.7108 Intermediate Similarity NPC207554
0.7076 Intermediate Similarity NPC300596
0.7076 Intermediate Similarity NPC237649
0.7066 Intermediate Similarity NPC471574
0.7059 Intermediate Similarity NPC17273
0.7059 Intermediate Similarity NPC135601
0.7059 Intermediate Similarity NPC141612
0.7059 Intermediate Similarity NPC473615
0.7049 Intermediate Similarity NPC64436
0.7048 Intermediate Similarity NPC83214
0.7045 Intermediate Similarity NPC276085
0.7027 Intermediate Similarity NPC270301
0.7021 Intermediate Similarity NPC229484
0.7015 Intermediate Similarity NPC153980
0.7015 Intermediate Similarity NPC6865
0.7011 Intermediate Similarity NPC295021
0.7006 Intermediate Similarity NPC143457
0.7006 Intermediate Similarity NPC225319
0.7005 Intermediate Similarity NPC259626
0.6989 Remote Similarity NPC222029
0.6984 Remote Similarity NPC292675
0.6973 Remote Similarity NPC91179
0.6965 Remote Similarity NPC72956
0.6952 Remote Similarity NPC2933
0.6941 Remote Similarity NPC136002
0.6927 Remote Similarity NPC138293
0.6927 Remote Similarity NPC113056
0.6914 Remote Similarity NPC209389
0.6911 Remote Similarity NPC92803
0.691 Remote Similarity NPC315368
0.6905 Remote Similarity NPC130251
0.69 Remote Similarity NPC71238
0.6898 Remote Similarity NPC256288
0.6898 Remote Similarity NPC159125
0.6893 Remote Similarity NPC61013
0.6893 Remote Similarity NPC153694
0.6893 Remote Similarity NPC123241
0.6893 Remote Similarity NPC211525
0.6885 Remote Similarity NPC214626
0.6885 Remote Similarity NPC139085
0.6885 Remote Similarity NPC251212
0.6882 Remote Similarity NPC11149
0.6879 Remote Similarity NPC109787
0.6872 Remote Similarity NPC293458
0.6872 Remote Similarity NPC476231
0.6872 Remote Similarity NPC286871
0.6871 Remote Similarity NPC314431
0.6864 Remote Similarity NPC301760
0.6864 Remote Similarity NPC471164
0.6864 Remote Similarity NPC316202
0.6854 Remote Similarity NPC263709
0.6854 Remote Similarity NPC148468
0.6854 Remote Similarity NPC310403
0.6854 Remote Similarity NPC97380
0.6854 Remote Similarity NPC243673
0.6854 Remote Similarity NPC63210
0.6854 Remote Similarity NPC193410
0.6847 Remote Similarity NPC471193
0.6847 Remote Similarity NPC471194
0.6836 Remote Similarity NPC29285
0.6829 Remote Similarity NPC471192
0.6828 Remote Similarity NPC248462
0.6826 Remote Similarity NPC267508
0.6818 Remote Similarity NPC471436
0.6816 Remote Similarity NPC248117
0.6806 Remote Similarity NPC18890
0.68 Remote Similarity NPC154602
0.6798 Remote Similarity NPC54981
0.6796 Remote Similarity NPC470069
0.6796 Remote Similarity NPC52059
0.6793 Remote Similarity NPC96901
0.6792 Remote Similarity NPC257490
0.6791 Remote Similarity NPC39822
0.6784 Remote Similarity NPC314287
0.6779 Remote Similarity NPC272174
0.6778 Remote Similarity NPC282339
0.6778 Remote Similarity NPC99632
0.6772 Remote Similarity NPC245741
0.6772 Remote Similarity NPC177684
0.6772 Remote Similarity NPC291962
0.6765 Remote Similarity NPC186284
0.6765 Remote Similarity NPC22082
0.6761 Remote Similarity NPC285381
0.6757 Remote Similarity NPC13367
0.6746 Remote Similarity NPC474896
0.6743 Remote Similarity NPC473329
0.674 Remote Similarity NPC313757
0.673 Remote Similarity NPC161956
0.673 Remote Similarity NPC258531
0.673 Remote Similarity NPC112373
0.6728 Remote Similarity NPC474926
0.6724 Remote Similarity NPC212799
0.6723 Remote Similarity NPC469903
0.6722 Remote Similarity NPC474058
0.6722 Remote Similarity NPC201424
0.6721 Remote Similarity NPC224970
0.6721 Remote Similarity NPC33507
0.6721 Remote Similarity NPC63047
0.6721 Remote Similarity NPC223595
0.6721 Remote Similarity NPC475248
0.6721 Remote Similarity NPC167724
0.6718 Remote Similarity NPC198401
0.6716 Remote Similarity NPC477173
0.6714 Remote Similarity NPC31097
0.671 Remote Similarity NPC276949
0.671 Remote Similarity NPC35850
0.6706 Remote Similarity NPC243162
0.6703 Remote Similarity NPC242269
0.6702 Remote Similarity NPC475685
0.6702 Remote Similarity NPC282092
0.67 Remote Similarity NPC477179
0.6685 Remote Similarity NPC472121
0.6685 Remote Similarity NPC161827
0.6684 Remote Similarity NPC105055
0.6684 Remote Similarity NPC97584
0.6684 Remote Similarity NPC22689
0.6683 Remote Similarity NPC470488
0.6667 Remote Similarity NPC17059
0.6667 Remote Similarity NPC477178
0.6667 Remote Similarity NPC2823
0.6667 Remote Similarity NPC264589
0.6667 Remote Similarity NPC113626
0.6667 Remote Similarity NPC477181
0.6667 Remote Similarity NPC254850
0.6667 Remote Similarity NPC477180
0.6667 Remote Similarity NPC200589
0.6667 Remote Similarity NPC473376
0.6649 Remote Similarity NPC99043
0.6649 Remote Similarity NPC218594
0.6649 Remote Similarity NPC117244
0.6649 Remote Similarity NPC133003
0.6649 Remote Similarity NPC473763
0.6648 Remote Similarity NPC144691
0.6646 Remote Similarity NPC476950

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC355 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.765 Intermediate Similarity NPD8240 Discontinued
0.756 Intermediate Similarity NPD3248 Phase 1
0.741 Intermediate Similarity NPD6017 Discontinued
0.7394 Intermediate Similarity NPD2820 Phase 3
0.7368 Intermediate Similarity NPD7072 Phase 2
0.7345 Intermediate Similarity NPD7795 Phase 2
0.7341 Intermediate Similarity NPD7599 Phase 2
0.7333 Intermediate Similarity NPD2365 Approved
0.7299 Intermediate Similarity NPD7600 Phase 2
0.7278 Intermediate Similarity NPD4939 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD6655 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD951 Approved
0.7225 Intermediate Similarity NPD6855 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD979 Approved
0.7176 Intermediate Similarity NPD4432 Discontinued
0.716 Intermediate Similarity NPD2949 Approved
0.716 Intermediate Similarity NPD2950 Approved
0.7143 Intermediate Similarity NPD4393 Approved
0.7143 Intermediate Similarity NPD33 Approved
0.7099 Intermediate Similarity NPD1919 Approved
0.7099 Intermediate Similarity NPD1920 Approved
0.7091 Intermediate Similarity NPD4077 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD6740 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD5748 Phase 2
0.7011 Intermediate Similarity NPD2790 Discontinued
0.6982 Remote Similarity NPD5024 Approved
0.6961 Remote Similarity NPD2369 Discontinued
0.6952 Remote Similarity NPD5923 Phase 1
0.6927 Remote Similarity NPD2288 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6768 Approved
0.6902 Remote Similarity NPD8022 Clinical (unspecified phase)
0.6893 Remote Similarity NPD5715 Clinical (unspecified phase)
0.6882 Remote Similarity NPD4464 Clinical (unspecified phase)
0.6879 Remote Similarity NPD4942 Approved
0.6868 Remote Similarity NPD3376 Clinical (unspecified phase)
0.6864 Remote Similarity NPD3625 Discontinued
0.6848 Remote Similarity NPD7662 Clinical (unspecified phase)
0.6848 Remote Similarity NPD6613 Clinical (unspecified phase)
0.6848 Remote Similarity NPD1527 Phase 2
0.6842 Remote Similarity NPD4948 Discontinued
0.6842 Remote Similarity NPD8103 Clinical (unspecified phase)
0.6825 Remote Similarity NPD6557 Phase 2
0.6823 Remote Similarity NPD5042 Phase 1
0.6813 Remote Similarity NPD3623 Clinical (unspecified phase)
0.6813 Remote Similarity NPD3622 Clinical (unspecified phase)
0.6798 Remote Similarity NPD7011 Discontinued
0.6796 Remote Similarity NPD8000 Clinical (unspecified phase)
0.6791 Remote Similarity NPD3989 Phase 3
0.6784 Remote Similarity NPD6176 Phase 1
0.6782 Remote Similarity NPD5942 Approved
0.6782 Remote Similarity NPD5941 Approved
0.6765 Remote Similarity NPD3434 Clinical (unspecified phase)
0.6761 Remote Similarity NPD6707 Clinical (unspecified phase)
0.6755 Remote Similarity NPD3990 Phase 3
0.6747 Remote Similarity NPD1541 Approved
0.6742 Remote Similarity NPD1663 Discontinued
0.674 Remote Similarity NPD3790 Phase 2
0.6736 Remote Similarity NPD5592 Clinical (unspecified phase)
0.6728 Remote Similarity NPD1036 Approved
0.6704 Remote Similarity NPD7735 Clinical (unspecified phase)
0.6702 Remote Similarity NPD3227 Phase 2
0.6701 Remote Similarity NPD5856 Discontinued
0.6688 Remote Similarity NPD1344 Phase 2
0.6687 Remote Similarity NPD1593 Approved
0.6686 Remote Similarity NPD4430 Phase 2
0.6667 Remote Similarity NPD8643 Discontinued
0.6667 Remote Similarity NPD7308 Discontinued
0.6667 Remote Similarity NPD2093 Discontinued
0.6667 Remote Similarity NPD2791 Discontinued
0.6667 Remote Similarity NPD7998 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1524 Phase 1
0.6649 Remote Similarity NPD1165 Clinical (unspecified phase)
0.6631 Remote Similarity NPD4091 Approved
0.663 Remote Similarity NPD3983 Phase 3
0.663 Remote Similarity NPD3984 Clinical (unspecified phase)
0.6628 Remote Similarity NPD6566 Discontinued
0.6627 Remote Similarity NPD6102 Clinical (unspecified phase)
0.6626 Remote Similarity NPD5577 Clinical (unspecified phase)
0.6626 Remote Similarity NPD5578 Approved
0.6615 Remote Similarity NPD5809 Phase 3
0.6614 Remote Similarity NPD7014 Clinical (unspecified phase)
0.6609 Remote Similarity NPD5932 Phase 3
0.6609 Remote Similarity NPD5933 Phase 3
0.6609 Remote Similarity NPD5931 Phase 3
0.6606 Remote Similarity NPD4895 Clinical (unspecified phase)
0.6606 Remote Similarity NPD1781 Discontinued
0.6603 Remote Similarity NPD1175 Approved
0.6602 Remote Similarity NPD7594 Clinical (unspecified phase)
0.6601 Remote Similarity NPD8493 Clinical (unspecified phase)
0.66 Remote Similarity NPD5552 Discontinued
0.6596 Remote Similarity NPD4092 Approved
0.659 Remote Similarity NPD5527 Clinical (unspecified phase)
0.659 Remote Similarity NPD5526 Phase 2
0.6585 Remote Similarity NPD2840 Approved
0.6585 Remote Similarity NPD797 Clinical (unspecified phase)
0.6566 Remote Similarity NPD2919 Clinical (unspecified phase)
0.6566 Remote Similarity NPD2918 Clinical (unspecified phase)
0.6556 Remote Similarity NPD7105 Phase 1
0.655 Remote Similarity NPD7728 Clinical (unspecified phase)
0.6548 Remote Similarity NPD7944 Discontinued
0.6548 Remote Similarity NPD941 Approved
0.6536 Remote Similarity NPD5086 Approved
0.6534 Remote Similarity NPD7794 Clinical (unspecified phase)
0.6533 Remote Similarity NPD4987 Clinical (unspecified phase)
0.6531 Remote Similarity NPD5937 Approved
0.6528 Remote Similarity NPD5820 Clinical (unspecified phase)
0.6527 Remote Similarity NPD1619 Phase 3
0.6519 Remote Similarity NPD2622 Approved
0.6519 Remote Similarity NPD8630 Approved
0.6512 Remote Similarity NPD6606 Clinical (unspecified phase)
0.651 Remote Similarity NPD4412 Phase 2
0.6509 Remote Similarity NPD7200 Approved
0.6508 Remote Similarity NPD3994 Approved
0.6508 Remote Similarity NPD3995 Approved
0.6508 Remote Similarity NPD3993 Approved
0.6508 Remote Similarity NPD3991 Approved
0.6508 Remote Similarity NPD3996 Approved
0.6508 Remote Similarity NPD3992 Approved
0.6505 Remote Similarity NPD6204 Clinical (unspecified phase)
0.6503 Remote Similarity NPD5551 Clinical (unspecified phase)
0.6502 Remote Similarity NPD6987 Phase 1
0.65 Remote Similarity NPD7000 Clinical (unspecified phase)
0.65 Remote Similarity NPD6999 Discontinued
0.6497 Remote Similarity NPD5181 Approved
0.6497 Remote Similarity NPD4888 Discontinued
0.6497 Remote Similarity NPD5179 Approved
0.6497 Remote Similarity NPD5180 Approved
0.6497 Remote Similarity NPD4682 Phase 2
0.6495 Remote Similarity NPD4515 Suspended
0.6494 Remote Similarity NPD1625 Approved
0.6492 Remote Similarity NPD2287 Clinical (unspecified phase)
0.649 Remote Similarity NPD7557 Clinical (unspecified phase)
0.649 Remote Similarity NPD3780 Phase 2
0.6489 Remote Similarity NPD3522 Approved
0.6489 Remote Similarity NPD4736 Clinical (unspecified phase)
0.6488 Remote Similarity NPD6486 Approved
0.6488 Remote Similarity NPD2846 Clinical (unspecified phase)
0.6488 Remote Similarity NPD7232 Discontinued
0.6488 Remote Similarity NPD6487 Approved
0.6477 Remote Similarity NPD5839 Clinical (unspecified phase)
0.6476 Remote Similarity NPD2813 Phase 3
0.6476 Remote Similarity NPD2812 Clinical (unspecified phase)
0.6474 Remote Similarity NPD7771 Discontinued
0.6474 Remote Similarity NPD3782 Discontinued
0.6474 Remote Similarity NPD3999 Approved
0.6474 Remote Similarity NPD3997 Approved
0.6474 Remote Similarity NPD2590 Clinical (unspecified phase)
0.6474 Remote Similarity NPD3998 Approved
0.6471 Remote Similarity NPD7001 Phase 3
0.6467 Remote Similarity NPD6359 Clinical (unspecified phase)
0.6464 Remote Similarity NPD6395 Phase 2
0.6464 Remote Similarity NPD6396 Clinical (unspecified phase)
0.6464 Remote Similarity NPD2351 Discontinued
0.6463 Remote Similarity NPD1640 Clinical (unspecified phase)
0.6462 Remote Similarity NPD6965 Clinical (unspecified phase)
0.6462 Remote Similarity NPD6608 Clinical (unspecified phase)
0.6457 Remote Similarity NPD5918 Discontinued
0.6455 Remote Similarity NPD5471 Phase 3
0.645 Remote Similarity NPD1874 Clinical (unspecified phase)
0.6448 Remote Similarity NPD2506 Approved
0.6447 Remote Similarity NPD7570 Approved
0.6447 Remote Similarity NPD7569 Approved
0.6447 Remote Similarity NPD8146 Phase 2
0.6442 Remote Similarity NPD4775 Clinical (unspecified phase)
0.6441 Remote Similarity NPD7441 Clinical (unspecified phase)
0.6441 Remote Similarity NPD8165 Discontinued
0.644 Remote Similarity NPD4329 Approved
0.644 Remote Similarity NPD4330 Approved
0.644 Remote Similarity NPD6878 Phase 2
0.644 Remote Similarity NPD6879 Phase 2
0.6436 Remote Similarity NPD7593 Clinical (unspecified phase)
0.6436 Remote Similarity NPD7817 Phase 1
0.6436 Remote Similarity NPD750 Phase 2
0.6436 Remote Similarity NPD5017 Discontinued
0.6433 Remote Similarity NPD5227 Clinical (unspecified phase)
0.6432 Remote Similarity NPD4796 Discontinued
0.6429 Remote Similarity NPD4499 Approved
0.6429 Remote Similarity NPD4300 Clinical (unspecified phase)
0.6425 Remote Similarity NPD6575 Clinical (unspecified phase)
0.6425 Remote Similarity NPD5982 Phase 2
0.6422 Remote Similarity NPD8115 Approved
0.6422 Remote Similarity NPD8114 Approved
0.6421 Remote Similarity NPD7587 Clinical (unspecified phase)
0.6421 Remote Similarity NPD5840 Discontinued
0.6421 Remote Similarity NPD5600 Discontinued
0.642 Remote Similarity NPD7602 Clinical (unspecified phase)
0.6418 Remote Similarity NPD7621 Clinical (unspecified phase)
0.6417 Remote Similarity NPD1573 Approved
0.6417 Remote Similarity NPD1575 Approved
0.6413 Remote Similarity NPD19 Approved
0.6413 Remote Similarity NPD1742 Approved
0.6413 Remote Similarity NPD1743 Approved
0.641 Remote Similarity NPD6141 Clinical (unspecified phase)
0.641 Remote Similarity NPD4988 Discontinued
0.6408 Remote Similarity NPD2443 Approved
0.6408 Remote Similarity NPD2442 Approved
0.6408 Remote Similarity NPD7666 Phase 3
0.6408 Remote Similarity NPD7665 Phase 2
0.6402 Remote Similarity NPD2584 Suspended
0.6402 Remote Similarity NPD7449 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data